OmniComm Systems, Inc.
Kim Rejndrup recently joined OmniComm as senior vice president-Product Development. Mr. Rejndrup spent nearly 20 years at Oracle Corporation, where he was a vice president of development for many clinical research applications, including systems for electronic data capture (EDC), clinical trials management, data management, medical coding and data warehousing. His experience is driving OmniComm’s products to new levels of innovation.
Title of Session: Are you ready for the new WHODrug Formats?
Description of Session:
Are you ready for the new WHODrug Formats?
The FDA is supporting submissions in the new WHODrug Global B3 or C3 formats as of 15-Mar-2018. By 15-Mar-2019, the older B2 and C formats will no longer be accepted.
- There are a number of significant changes that will affect your coding practices and reporting systems. Do your systems support a drug name of 1000+ characters?
- How well is your coding system learning from your decisions, and how can you teach it to better aid you in coding decisions?
- Can the coding system “see” past the clutter in verbatim terms? For example, “5/5/18 FX to left leg” should code to the MedDRA term “Leg fracture”.
In this presentation, renowned industry expert Kim Rejndrup, holder of two coding patents, will walk you through the considerations in adopting the new WHO Drug formats. He will also cover the general principles of what you should expect of a coding system today.
Evaluate if your medical coding system can support WHODrug Global B3 or C3 formats
Evaluate if your EDC or Safety systems can support WHODrug Global B3 or C3 formats
Evaluate if your coding system is as effective as it should be